产品特点
1
_ _
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Vecoxan 2.5 mg/ml Oral Suspension for lambs and calves
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
_ACTIVE SUBSTANCE: _
Diclazuril
2.5 mg
_ _
_EXCIPIENTS: _
Methyl para hydroxybenzoate (E218)
1.8 mg
Propyl para hydroxybenzoate (E216)
0.2 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
White, oral suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Ovine (lambs) and bovine (calves).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In lambs:
Prevention of coccidiosis caused by _Eimeria
crandallis_ and _Eimeria ovinoidalis_.
In calves:
Prevention of coccidiosis caused by _Eimeria bovis_ and _Eimeria
zuernii_.
If there is no recent and confirmed
history of clinical coccidiosis,
the presence of coccidia in the flock
or herd should be confirmed by faecal sampling prior to
treatment.
4.3
CONTRAINDICATIONS
None known.
2
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
To ensure a correct dosage, body weight should be determined
as accurately as possible.
Calves: in certain cases,
only a transient reduction of oocyst shedding may be achieved.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Shake well before use.
The preferred timing of treatment is directed by the known epidemiology of _Eimeria _
_spp._ and the presence of coccidia in the flock or herd
should be confirmed by faecal sampling prior
to treatment, if there is no recent and confirmed
history of clinical coccidiosis.
Coccidiosis is an indicator of insufficient hygiene in the flock/pen. It is
阅读完整的文件
产品特点 